January 21, 2015

Eisai on Tuesday announced the launch of a new savings card for Belviq (lorcaserin HCl) CIV, the most-prescribed branded FDA-approved prescription drug therapy for chronic weight management.

December 29, 2014

Novo Nordisk last week announced that the Food and Drug Administration approved the company's new drug application for Saxenda, a once-daily glucagon-like peptide-1 receptor agonist used as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adults.

November 3, 2014

Research shows that 140 million American adults (about 65%) are recommended for behavioral weight-loss treatment, with 83% of those (or 116 million) considered for pharmacotherapy, according to a report released by The Obesity Society on Monday.

September 11, 2014

The Food and Drug Administration approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as a chronic weight-management option. 

September 3, 2014

The Annals of Internal Medicine just published results of a National Institutes of Health trial titled "Effects of low-carbohydrate and low-fat diets," in which a low-carbohydrate diet was found to be more effective both for weight loss and cardiovascular risk factor reduction than a low-fat diet, Atkins Nutritionals announced Tuesday.

December 30, 2013

Drug maker Merck is starting a new business designed to provide weight-management intervention services to employers, patients and healthcare professionals, the company said.

February 1, 2013

Patients who take a drug for losing weight may experience improvement in multiple cardiovascular disease risk factors, according to a new study.

September 19, 2012

Drug maker Vivus has released what it called the first new drug in 13 years for chronic weight management in adults.